A study to identify the optimal preemptive analgesic dose of gabapenti
Phase 4
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2023/10/058395
- Lead Sponsor
- ourdes hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) ASA 1 and 2 patients undergoing elective lumbar laminectomy under general anesthesia
Exclusion Criteria
1) ASA 3 and 4
2) Pregnant and lactating patients
3) Patients on maintenance dose of gabapentin for any indication
4) Emergency surgery
5) Drug allergy to gabapentin or any common drugs that are used during general anesthesia
6) Prolonged surgery more than 4 hours
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method